> NRI is on heavy accumulation.

> Its a very good buy at the moment.
> Nice consolidation ready to move up in the coming weeks.
> Watch for a close above 40 cents On the TSE.
> Then it could quickly move up to 60 cents before aprroval.
> And could see 1.20$ to 1.50$ after approbation of the FDA.
> Approbation chance are 85%.
> Very good risq/reward ratio.
> Good luck everyone.

> sorry but if this stock gets approved it will be much higher then
> 1.20-1.50$...

> On Jun 27, 5:58 pm, "OPC!" <jun...@rocketmail.com> wrote:

> > NRI is on heavy accumulation.

> > Its a very good buy at the moment.
> > Nice consolidation ready to move up in the coming weeks.
> > Watch for a close above 40 cents On the TSE.
> > Then it could quickly move up to 60 cents before aprroval.
> > And could see 1.20$ to 1.50$ after approbation of the FDA.
> > Approbation chance are 85%.
> > Very good risq/reward ratio.
> > Good luck everyone.

> Told you so.

> NRI is still a great buy now that its close above 40 cents and it
> could quickly move to 60 cents.

> And for the idiot Silvo. Well if you knew Finance you would know that
> NRI cannot go higher than 1$

> Given its get a 10-15$ royalty on peensaid on possible US sale of
> 300-400 millions maybe

> around of 30-35 millions of profit give us a shares price of 0.75$ and
> a PE of 10.

> Told you so.

> NRI is still a great buy now that its close above 40 cents and it
> could quickly move to 60 cents.

> And for the idiot Silvo. Well if you knew Finance you would know that
> NRI cannot go higher than 1$

> Given its get a 10-15$ royalty on peensaid on possible US sale of
> 300-400 millions maybe

> around of 30-35 millions of profit give us a shares price of 0.75$ and
> a PE of 10.

> Hey OPC do your homework better my friend !!!

> first of all NRI already earns money in other countries , they should
> win around 20 millions only with canada and greece for 2009, they also
> got 10 millions from their partner and will get 20 millions more if
> FDA approved Pennsaid. You also have to add 20% royalties of lets say
> 300 millions sales in USA so 60 millions, you also forgot the 100
> millions for milestone and range sales.
> So we have around 150 millions$ at least for 2010 and im sorry but
> this kind of biotechs usually have a PE of 15 or 20 but never 10 !!!
> now guess the pps in August 6th ??? do the math my friend !

> On 5 juil, 14:35, "OPC!" <jun...@rocketmail.com> wrote:

> > Told you so.

> > NRI is still a great buy now that its close above 40 cents and it
> > could quickly move to 60 cents.

> > And for the idiot Silvo. Well if you knew Finance you would know that
> > NRI cannot go higher than 1$

> > Given its get a 10-15$ royalty on peensaid on possible US sale of
> > 300-400 millions maybe

> > around of 30-35 millions of profit give us a shares price of 0.75$ and
> > a PE of 10.

> Anyone have thoughts on the slow dip thats starting to hurt?

> On Jul 5, 12:09 pm, kangaroo <kangaroo_pa...@hotmail.com> wrote:

> > Hey OPC do your homework better my friend !!!

> > first of all NRI already earns money in other countries , they should
> > win around 20 millions only with canada and greece for 2009, they also
> > got 10 millions from their partner and will get 20 millions more if
> > FDA approved Pennsaid. You also have to add 20% royalties of lets say
> > 300 millions sales in USA so 60 millions, you also forgot the 100
> > millions for milestone and range sales.
> > So we have around 150 millions$ at least for 2010 and im sorry but
> > this kind of biotechs usually have a PE of 15 or 20 but never 10 !!!
> > now guess the pps in August 6th ??? do the math my friend !

> > On 5 juil, 14:35, "OPC!" <jun...@rocketmail.com> wrote:

> > > Told you so.

> > > NRI is still a great buy now that its close above 40 cents and it
> > > could quickly move to 60 cents.

> > > And for the idiot Silvo. Well if you knew Finance you would know that
> > > NRI cannot go higher than 1$

> > > Given its get a 10-15$ royalty on peensaid on possible US sale of
> > > 300-400 millions maybe

> > > around of 30-35 millions of profit give us a shares price of 0.75$ and
> > > a PE of 10.- Hide quoted text -

> - Show quoted text -

> It's not a dip, it's normalizing back to where we were for a week. .34

> The .39 we got on Friday was because of high volume due to American
> markets being closed.

> On Jul 6, 3:26 pm, Big MacK <mackenzie...@yahoo.ca> wrote:

> > Anyone have thoughts on the slow dip thats starting to hurt?

> > On Jul 5, 12:09 pm, kangaroo <kangaroo_pa...@hotmail.com> wrote:

> > > Hey OPC do your homework better my friend !!!

> > > first of all NRI already earns money in other countries , they should
> > > win around 20 millions only with canada and greece for 2009, they also
> > > got 10 millions from their partner and will get 20 millions more if
> > > FDA approved Pennsaid. You also have to add 20% royalties of lets say
> > > 300 millions sales in USA so 60 millions, you also forgot the 100
> > > millions for milestone and range sales.
> > > So we have around 150 millions$ at least for 2010 and im sorry but
> > > this kind of biotechs usually have a PE of 15 or 20 but never 10 !!!
> > > now guess the pps in August 6th ??? do the math my friend !

> > > On 5 juil, 14:35, "OPC!" <jun...@rocketmail.com> wrote:

> > > > Told you so.

> > > > NRI is still a great buy now that its close above 40 cents and it
> > > > could quickly move to 60 cents.

> > > > And for the idiot Silvo. Well if you knew Finance you would know that
> > > > NRI cannot go higher than 1$

> > > > Given its get a 10-15$ royalty on peensaid on possible US sale of
> > > > 300-400 millions maybe

> > > > around of 30-35 millions of profit give us a shares price of 0.75$ and
> > > > a PE of 10.- Hide quoted text -

> > - Show quoted text -

> It's not normalizing it's putting in a new support level. Essentially
> this is the same that we've seen after every sharp increase. If it
> were going back to 0.34 it should have gotten there today but, since
> we are most likely going to see new average volumes nothing's really
> clear at this point. I'll be surprised if we don't see week over week
> gains from until the announcement of the FDA delaying their
> announcement! LOL.

> Hey I need to laugh after looking at the rest of my holdings.

> On Jul 6, 3:55 pm, Vinny <vancemend...@gmail.com> wrote:

> > It's not a dip, it's normalizing back to where we were for a week. .34

> > The .39 we got on Friday was because of high volume due to American
> > markets being closed.

> > On Jul 6, 3:26 pm, Big MacK <mackenzie...@yahoo.ca> wrote:

> > > Anyone have thoughts on the slow dip thats starting to hurt?

> > > On Jul 5, 12:09 pm, kangaroo <kangaroo_pa...@hotmail.com> wrote:

> > > > Hey OPC do your homework better my friend !!!

> > > > first of all NRI already earns money in other countries , they should
> > > > win around 20 millions only with canada and greece for 2009, they also
> > > > got 10 millions from their partner and will get 20 millions more if
> > > > FDA approved Pennsaid. You also have to add 20% royalties of lets say
> > > > 300 millions sales in USA so 60 millions, you also forgot the 100
> > > > millions for milestone and range sales.
> > > > So we have around 150 millions$ at least for 2010 and im sorry but
> > > > this kind of biotechs usually have a PE of 15 or 20 but never 10 !!!
> > > > now guess the pps in August 6th ??? do the math my friend !

> > > > On 5 juil, 14:35, "OPC!" <jun...@rocketmail.com> wrote:

> > > > > Told you so.

> > > > > NRI is still a great buy now that its close above 40 cents and it
> > > > > could quickly move to 60 cents.

> > > > > And for the idiot Silvo. Well if you knew Finance you would know that
> > > > > NRI cannot go higher than 1$

> > > > > Given its get a 10-15$ royalty on peensaid on possible US sale of
> > > > > 300-400 millions maybe

> > > > > around of 30-35 millions of profit give us a shares price of 0.75$ and
> > > > > a PE of 10.- Hide quoted text -

> > > - Show quoted text -

> Yeah Adam it looks like the last spike to a T. I got back in today and
> will be sitting on them...no more selling..promise!

> My port is bleeding badly today. Guess that's what I get for investing
> lots in commodities. I am not worried but it sure takes away funds for
> bottom fishing and doubling down.

> On Jul 6, 1:16 pm, AdamJ <ajtimper...@gmail.com> wrote:

> > It's not normalizing it's putting in a new support level. Essentially
> > this is the same that we've seen after every sharp increase. If it
> > were going back to 0.34 it should have gotten there today but, since
> > we are most likely going to see new average volumes nothing's really
> > clear at this point. I'll be surprised if we don't see week over week
> > gains from until the announcement of the FDA delaying their
> > announcement! LOL.

> > Hey I need to laugh after looking at the rest of my holdings.

> > On Jul 6, 3:55 pm, Vinny <vancemend...@gmail.com> wrote:

> > > It's not a dip, it's normalizing back to where we were for a week. .34

> > > The .39 we got on Friday was because of high volume due to American
> > > markets being closed.

> > > On Jul 6, 3:26 pm, Big MacK <mackenzie...@yahoo.ca> wrote:

> > > > Anyone have thoughts on the slow dip thats starting to hurt?

> > > > On Jul 5, 12:09 pm, kangaroo <kangaroo_pa...@hotmail.com> wrote:

> > > > > Hey OPC do your homework better my friend !!!

> > > > > first of all NRI already earns money in other countries , they should
> > > > > win around 20 millions only with canada and greece for 2009, they also
> > > > > got 10 millions from their partner and will get 20 millions more if
> > > > > FDA approved Pennsaid. You also have to add 20% royalties of lets say
> > > > > 300 millions sales in USA so 60 millions, you also forgot the 100
> > > > > millions for milestone and range sales.
> > > > > So we have around 150 millions$ at least for 2010 and im sorry but
> > > > > this kind of biotechs usually have a PE of 15 or 20 but never 10 !!!
> > > > > now guess the pps in August 6th ??? do the math my friend !

> > > > > On 5 juil, 14:35, "OPC!" <jun...@rocketmail.com> wrote:

> > > > > > Told you so.

> > > > > > NRI is still a great buy now that its close above 40 cents and it
> > > > > > could quickly move to 60 cents.

> > > > > > And for the idiot Silvo. Well if you knew Finance you would know that
> > > > > > NRI cannot go higher than 1$

> > > > > > Given its get a 10-15$ royalty on peensaid on possible US sale of
> > > > > > 300-400 millions maybe

> > > > > > around of 30-35 millions of profit give us a shares price of 0.75$ and
> > > > > > a PE of 10.- Hide quoted text -

> > > > - Show quoted text -

> Yeah Adam it looks like the last spike to a T. I got back in today and
> will be sitting on them...no more selling..promise!

> My port is bleeding badly today. Guess that's what I get for investing
> lots in commodities. I am not worried but it sure takes away funds for
> bottom fishing and doubling down.

> On Jul 6, 1:16 pm, AdamJ <ajtimper...@gmail.com> wrote:

> > It's not normalizing it's putting in a new support level. Essentially
> > this is the same that we've seen after every sharp increase. If it
> > were going back to 0.34 it should have gotten there today but, since
> > we are most likely going to see new average volumes nothing's really
> > clear at this point. I'll be surprised if we don't see week over week
> > gains from until the announcement of the FDA delaying their
> > announcement! LOL.

> > Hey I need to laugh after looking at the rest of my holdings.

> > On Jul 6, 3:55 pm, Vinny <vancemend...@gmail.com> wrote:

> > > It's not a dip, it's normalizing back to where we were for a week. .34

> > > The .39 we got on Friday was because of high volume due to American
> > > markets being closed.

> > > On Jul 6, 3:26 pm, Big MacK <mackenzie...@yahoo.ca> wrote:

> > > > Anyone have thoughts on the slow dip thats starting to hurt?

> > > > On Jul 5, 12:09 pm, kangaroo <kangaroo_pa...@hotmail.com> wrote:

> > > > > Hey OPC do your homework better my friend !!!

> > > > > first of all NRI already earns money in other countries , they should
> > > > > win around 20 millions only with canada and greece for 2009, they also
> > > > > got 10 millions from their partner and will get 20 millions more if
> > > > > FDA approved Pennsaid. You also have to add 20% royalties of lets say
> > > > > 300 millions sales in USA so 60 millions, you also forgot the 100
> > > > > millions for milestone and range sales.
> > > > > So we have around 150 millions$ at least for 2010 and im sorry but
> > > > > this kind of biotechs usually have a PE of 15 or 20 but never 10 !!!
> > > > > now guess the pps in August 6th ??? do the math my friend !

> > > > > On 5 juil, 14:35, "OPC!" <jun...@rocketmail.com> wrote:

> > > > > > Told you so.

> > > > > > NRI is still a great buy now that its close above 40 cents and it
> > > > > > could quickly move to 60 cents.

> > > > > > And for the idiot Silvo. Well if you knew Finance you would know that
> > > > > > NRI cannot go higher than 1$

> > > > > > Given its get a 10-15$ royalty on peensaid on possible US sale of
> > > > > > 300-400 millions maybe

> > > > > > around of 30-35 millions of profit give us a shares price of 0.75$ and
> > > > > > a PE of 10.- Hide quoted text -

> > > > - Show quoted text -

> Share price has very little if anything at all to do with profit.

> Look at TCK.B , it went from $4 to $20 in a month with no change in
> profits or any fundamentals , strictly market sentiment.

> To say this one can't go higher than $1 because of some wierd profit/
> share pice ratio has no basis.

> Hype and market sentiment drive share prices in the short term all the
> time.

> If enough people want in on this company and are willing to pay the
> price it can go to any limit , at least temporarily.

> There is still even a chance they will not get approval and it will go
> back to a few cents.

> In the context of corporate financial statements of publicly traded
> companies, the NAVPS, more commonly referred to as book value per
> share, is usually below the market price per share. The historical
> cost accounting principle, which tends to understate certain asset
> values, and the supply and demand forces of the marketplace generally
> push stock prices above book value per share valuations

> On Jul 4, 11:35 pm, "OPC!" <jun...@rocketmail.com> wrote:

> > Told you so.

> > NRI is still a great buy now that its close above 40 cents and it
> > could quickly move to 60 cents.

> > And for the idiot Silvo. Well if you knew Finance you would know that
> > NRI cannot go higher than 1$

> > Given its get a 10-15$ royalty on peensaid on possible US sale of
> > 300-400 millions maybe

> > around of 30-35 millions of profit give us a shares price of 0.75$ and
> > a PE of 10.- Hide quoted text -

> - Show quoted text -

> Hey OPC do your homework better my friend !!!

> first of all NRI already earns money in other countries , they should
> win around 20 millions only with canada and greece for 2009, they also
> got 10 millions from their partner and will get 20 millions more if
> FDA approved Pennsaid. You also have to add 20% royalties of lets say
> 300 millions sales in USA so 60 millions, you also forgot the 100
> millions for milestone and range sales.
> So we have around 150 millions$ at least for 2010 and im sorry but
> this kind of biotechs usually have a PE of 15 or 20 but never 10 !!!
> now guess the pps in August 6th ??? do the math my friend !

> On 5 juil, 14:35, "OPC!" <jun...@rocketmail.com> wrote:

> > Told you so.

> > NRI is still a great buy now that its close above 40 cents and it
> > could quickly move to 60 cents.

> > And for the idiot Silvo. Well if you knew Finance you would know that
> > NRI cannot go higher than 1$

> > Given its get a 10-15$ royalty on peensaid on possible US sale of
> > 300-400 millions maybe

> > around of 30-35 millions of profit give us a shares price of 0.75$ and
> > a PE of 10.- Hide quoted text -

> - Show quoted text -

> Share price has very little if anything at all to do with profit.

> Look at TCK.B , it went from $4 to $20 in a month with no change in
> profits or any fundamentals , strictly market sentiment.

> To say this one can't go higher than $1 because of some wierd profit/
> share pice ratio has no basis.

> Hype and market sentiment drive share prices in the short term all the
> time.

> If enough people want in on this company and are willing to pay the
> price it can go to any limit , at least temporarily.

> There is still even a chance they will not get approval and it will go
> back to a few cents.

> In the context of corporate financial statements of publicly traded
> companies, the NAVPS, more commonly referred to as book value per
> share, is usually below the market price per share. The historical
> cost accounting principle, which tends to understate certain asset
> values, and the supply and demand forces of the marketplace generally
> push stock prices above book value per share valuations

> On Jul 4, 11:35 pm, "OPC!" <jun...@rocketmail.com> wrote:

> > Told you so.

> > NRI is still a great buy now that its close above 40 cents and it
> > could quickly move to 60 cents.

> > And for the idiot Silvo. Well if you knew Finance you would know that
> > NRI cannot go higher than 1$

> > Given its get a 10-15$ royalty on peensaid on possible US sale of
> > 300-400 millions maybe

> > around of 30-35 millions of profit give us a shares price of 0.75$ and
> > a PE of 10.

> TCK.B did not go from $4 to $20 in a single month.

> On Jul 5, 8:43 am, looby <jack.nicholsons.underw...@gmail.com> wrote:

> > Share price has very little if anything at all to do with profit.

> > Look at TCK.B , it went from $4 to $20 in a month with no change in
> > profits or any fundamentals , strictly market sentiment.

> > To say this one can't go higher than $1 because of some wierd profit/
> > share pice ratio has no basis.

> > Hype and market sentiment drive share prices in the short term all the
> > time.

> > If enough people want in on this company and are willing to pay the
> > price it can go to any limit , at least temporarily.

> > There is still even a chance they will not get approval and it will go
> > back to a few cents.

> > In the context of corporate financial statements of publicly traded
> > companies, the NAVPS, more commonly referred to as book value per
> > share, is usually below the market price per share. The historical
> > cost accounting principle, which tends to understate certain asset
> > values, and the supply and demand forces of the marketplace generally
> > push stock prices above book value per share valuations

> > On Jul 4, 11:35 pm, "OPC!" <jun...@rocketmail.com> wrote:

> > > Told you so.

> > > NRI is still a great buy now that its close above 40 cents and it
> > > could quickly move to 60 cents.

> > > And for the idiot Silvo. Well if you knew Finance you would know that
> > > NRI cannot go higher than 1$

> > > Given its get a 10-15$ royalty on peensaid on possible US sale of
> > > 300-400 millions maybe

> > > around of 30-35 millions of profit give us a shares price of 0.75$ and
> > > a PE of 10.- Hide quoted text -

> - Show quoted text -